Silva v. Lovelace Health System, Inc.

CourtNew Mexico Court of Appeals
DecidedMay 6, 2014
Docket31,723
StatusPublished

This text of Silva v. Lovelace Health System, Inc. (Silva v. Lovelace Health System, Inc.) is published on Counsel Stack Legal Research, covering New Mexico Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Silva v. Lovelace Health System, Inc., (N.M. Ct. App. 2014).

Opinion

IN THE COURT OF APPEALS OF THE STATE OF NEW MEXICO

Opinion Number: _____________

Filing Date: May 6, 2014

Docket No. 31,723

ANTHONY and CHENG SILVA, Individually and as Personal Representatives of the Estate of SUSAN SILVA, Deceased, and ANTHONY SILVA, JR., and JINLEN SILVA, as Surviving Siblings of SUSAN SILVA,

Plaintiffs-Appellees,

v.

LOVELACE HEALTH SYSTEM, INC., and DR. ISABEL LOPEZ-COLBERG,

Defendants-Appellants.

APPEAL FROM THE DISTRICT COURT OF VALENCIA COUNTY William A. Sanchez, District Judge

Bowles and Crow Jason Bowles B. J. Crow Albuquerque, NM

Foster, Rieder & Jackson, P.C. Travis G. Jackson Albuquerque, NM

for Appellees

Domenici Law Firm, P.C. Pete V. Domenici, Jr. Lorraine Hollingsworth Albuquerque, NM

1 Rodey, Dickason, Sloan, Akin & Robb, P.A. Edward R. Ricco Jocelyn Drennan Albuquerque, NM

for Appellants

OPINION

FRY, Judge.

{1} In this case, we address the doctrine of independent intervening cause in circumstances where the evidence was conflicting as to whether the conduct of Plaintiffs’ relative, the decedent, was (1) intentional and (2) foreseeable. Plaintiffs sued Lovelace Health System, Inc., and Dr. Isabel Lopez-Colberg (collectively, Defendants) for the wrongful suicide death of Susan Silva (Decedent) on the theory that Dr. Lopez-Colberg negligently prescribed Decedent twelve months of antidepressant refills without requiring follow-up visits while knowing that the drug may cause suicidality in patients. Defendants raised several defenses to Plaintiffs’ claims, including the defense that Decedent’s overdose on antidepressants and resulting suicide constituted an independent intervening cause that eliminated any liability they might have for their own negligence. The district court refused to instruct the jury on this defense. On appeal from a jury verdict against them, Defendants argue that the district court erred in (1) refusing to instruct the jury on suicide as an independent intervening cause, and (2) denying Defendants’ motion for a directed verdict on Plaintiffs’ loss of consortium claims.

{2} On the first issue, we acknowledge that, in cases involving only the negligence of the parties, our Supreme Court has virtually eliminated the defense of independent intervening cause. See Torres v. El Paso Elec. Co., 1999-NMSC-029, ¶ 13,127 N.M. 729, 987 P.2d 386, overruled on other grounds by Herrera v. Quality Pontiac, 2003-NMSC-018, ¶ 33, 134 N.M. 43, 73 P.3d 181. However, independent intervening cause may still apply in cases where there are intentional or criminal acts or forces of nature that are unforeseeable. In this case, we conclude that the evidence gave rise to reasonable inferences that Decedent’s acts of overdosing on antidepressants and committing suicide may have been intentional rather than negligent and that these acts may have been unforeseeable. This evidence could theoretically lead a properly instructed jury to conclude that these intentional acts constituted an independent intervening cause that interrupted and negated any negligence by Dr. Lopez- Colberg in prescribing the drug to Decedent. We therefore hold that the district court erred by failing to instruct the jury on Decedent’s suicide as an independent intervening cause. It was for the jury, not the district court, to determine whether Decedent’s suicide was intentional and foreseeable to Dr. Lopez-Colberg. We therefore reverse and remand.

{3} On the second issue, which we address in the event it arises on remand, we hold that Plaintiffs failed to show the degree of mutual dependence required to support their loss of

2 consortium claims.

I. BACKGROUND

{4} This wrongful death case is based on the alleged negligent treatment of Decedent by Defendants. As stated above, the theory of Plaintiffs’ case was that Dr. Lopez-Colberg gave Decedent a twelve-month prescription for paroxetine (Paxil), which allegedly “causes suicidality,” and failed to follow up or monitor Decedent. As a result, Plaintiffs claimed, Decedent “engaged in a self-mutilation suicide.” The evidence presented to the jury at trial included the following.

{5} In May 2004, Dr. Lopez-Colberg began treating Decedent and diagnosed her with anxiety. Dr. Lopez-Colberg prescribed Paxil, a selective serotonin re-uptake inhibitor, commonly used to treat depression and anxiety, at ten milligrams per day. During the next seven months, Dr. Lopez-Colberg saw Decedent four times to address persistent symptoms, and she adjusted her Paxil dosage to twenty milligrams. In November 2004, Decedent changed insurance carriers and began treatment with another physician.

{6} In October 2005, Decedent returned to Dr. Lopez-Colberg’s care. When she returned to care, Decedent was taking twenty milligrams of Paxil a day, plus Ativan for breakthrough anxiety. Dr. Lopez-Colberg noted that Decedent had “serotonin syndrome,” which she clarified meant that Decedent was experiencing serotonin withdrawal when she forgot to take her Paxil. Dr. Lopez-Colberg also noted that Decedent was experiencing many psychosocial stressors, which Decedent declined to detail. Decedent’s use of Ativan indicated to Dr. Lopez-Colberg that Decedent’s anxiety was not under control, and Dr. Lopez-Colberg wanted to increase the Paxil dosage. Dr. Lopez-Colberg wrote Decedent two prescriptions: one month’s worth of Ativan and one year’s worth of Paxil (one month’s worth with eleven authorized refills). At this point, Decedent had been on twenty milligrams of Paxil for seventeen months. After Dr. Lopez-Colberg prescribed the medication, there were no follow-up appointments scheduled, although Decedent was to return “when she fe[lt] that she would like to increase the Paxil.”

{7} According to a June 2005 FDA advisory, “[s]everal recent publications suggest the possibility of increased risk for suicidal behavior in adults being treated with antidepressants.” However, Dr. Lopez-Colberg’s patient notes for Decedent’s visits did not indicate that Decedent had any thoughts of suicide.

{8} Decedent’s friends and family reported that Decedent began exhibiting very strange behavior in April 2006, which was over five months after Decedent’s last visit with Dr. Lopez-Colberg. On April 13, 2006, Decedent was found dead in her apartment, having taken her own life. Toxicology analysis determined that Decedent had twenty-two times the therapeutic dose of Paxil in her system at the time of her death. It was determined that she had obtained thirty Paxil tablets three days prior to her death, and there were no pills left in that thirty-day prescription.

3 {9} Decedent’s parents filed suit asserting negligence and wrongful death claims against Defendants. Decedent’s parents and two surviving siblings also asserted claims for loss of consortium. Plaintiffs’ claims against Defendants were tried to a jury, and Defendants argued that the jury should be instructed on their theory that Decedent’s suicide constituted an independent intervening cause that absolved them of liability. The district court refused the requested instructions, and the jury returned a verdict for Plaintiffs.

{10} On appeal, Defendants argue that the district court erroneously refused to instruct the jury on their theory that Decedent’s suicide was an independent intervening cause. They also argue that the district court erred in denying their motion for directed verdict on Plaintiffs’ claims for loss of consortium. We address each contention in turn.

II. DISCUSSION

A. Independent Intervening Cause Instruction

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wachocki v. Bernalillo County Sheriff's Department
2011 NMSC 039 (New Mexico Supreme Court, 2011)
Wachocki v. Bernalillo County Sheriff's Department
2010 NMCA 21 (New Mexico Court of Appeals, 2009)
Sunwest Bank of Clovis, N.A. v. Garrett
823 P.2d 912 (New Mexico Supreme Court, 1992)
Folz v. State
797 P.2d 246 (New Mexico Supreme Court, 1990)
Ramirez v. Armstrong
673 P.2d 822 (New Mexico Supreme Court, 1983)
Melnick v. State Farm Mutual Automobile Insurance
749 P.2d 1105 (New Mexico Supreme Court, 1988)
Davis v. Board of County Commissioners
1999 NMCA 110 (New Mexico Court of Appeals, 1999)
Torres v. El Paso Electric Co.
1999 NMSC 029 (New Mexico Supreme Court, 1999)
Calkins v. Cox Estates
792 P.2d 36 (New Mexico Supreme Court, 1990)
City of Belen v. Harrell
603 P.2d 711 (New Mexico Supreme Court, 1979)
McNeill v. Burlington Resources Oil & Gas Co.
2008 NMSC 022 (New Mexico Supreme Court, 2008)
Herrera Ex Rel. Estate of Ruiz v. Quality Pontiac
2003 NMSC 018 (New Mexico Supreme Court, 2003)
Chamberland v. Roswell Osteopathic Clinic, Inc.
2001 NMCA 045 (New Mexico Court of Appeals, 2001)
Benavidez v. City of Gallup
2007 NMSC 026 (New Mexico Supreme Court, 2007)
Solorzano v. Bristow
2004 NMCA 136 (New Mexico Court of Appeals, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Silva v. Lovelace Health System, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/silva-v-lovelace-health-system-inc-nmctapp-2014.